226 related articles for article (PubMed ID: 30926646)
1. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Radiotherapy of Pediatric Solid Tumors Using a Radioiodinated Alkyl-Phospholipid Ether Analog.
Baiu DC; Marsh IR; Boruch AE; Shahi A; Bhattacharya S; Jeffery JJ; Zhao Q; Hall LT; Weichert JP; Bednarz BP; Otto M
J Nucl Med; 2018 Feb; 59(2):244-250. PubMed ID: 28747518
[TBL] [Abstract][Full Text] [Related]
3. Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.
Marsh IR; Li C; Grudzinski J; Jeffery J; Longhurst C; Adam DP; Hernandez R; Weichert JP; Harari PM; Bednarz BP
Cancer Biother Radiopharm; 2023 Sep; 38(7):458-467. PubMed ID: 37022739
[No Abstract] [Full Text] [Related]
4. Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems.
Morris ZS; Weichert JP; Saker J; Armstrong EA; Besemer A; Bednarz B; Kimple RJ; Harari PM
Radiother Oncol; 2015 Sep; 116(3):504-9. PubMed ID: 26123834
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.
Besemer AE; Grudzinski JJ; Weichert JP; Hall LT; Bednarz BP
Cancer Biother Radiopharm; 2019 Feb; 34(1):13-23. PubMed ID: 30351218
[TBL] [Abstract][Full Text] [Related]
6. CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer.
Grudzinski J; Marsh I; Titz B; Jeffery J; Longino M; Kozak K; Lange K; Larrabee J; Weichmann A; Moser A; Bednarz B
Cancer Biother Radiopharm; 2018 Apr; 33(3):87-95. PubMed ID: 29641256
[TBL] [Abstract][Full Text] [Related]
7. Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
Huang SY; Bolch WE; Lee C; Van Brocklin HF; Pampaloni MH; Hawkins RA; Sznewajs A; DuBois SG; Matthay KK; Seo Y
Mol Imaging Biol; 2015 Apr; 17(2):284-94. PubMed ID: 25145966
[TBL] [Abstract][Full Text] [Related]
8. A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.
Grudzinski JJ; Titz B; Kozak K; Clarke W; Allen E; Trembath L; Stabin M; Marshall J; Cho SY; Wong TZ; Mortimer J; Weichert JP
PLoS One; 2014; 9(11):e111652. PubMed ID: 25402488
[TBL] [Abstract][Full Text] [Related]
9. Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404.
Besemer AE; Titz B; Grudzinski JJ; Weichert JP; Kuo JS; Robins HI; Hall LT; Bednarz BP
Phys Med Biol; 2017 Jul; 62(15):6008-6025. PubMed ID: 28682793
[TBL] [Abstract][Full Text] [Related]
10. [
Hall LT; Titz B; Baidya N; van der Kolk AG; Robins HI; Otto M; Perlman SB; Weichert JP; Kuo JS
Mol Imaging Biol; 2020 Apr; 22(2):434-443. PubMed ID: 31183841
[TBL] [Abstract][Full Text] [Related]
11. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.
Gaze MN; Chang YC; Flux GD; Mairs RJ; Saran FH; Meller ST
Cancer Biother Radiopharm; 2005 Apr; 20(2):195-9. PubMed ID: 15869455
[TBL] [Abstract][Full Text] [Related]
13. Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for
Seo Y; Huh Y; Huang SY; Hernandez-Pampaloni JM; Hawkins RA; Gustafson WC; Vo KT; Matthay KK
Med Phys; 2019 May; 46(5):2477-2486. PubMed ID: 30761545
[TBL] [Abstract][Full Text] [Related]
14. Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma.
Marino R; Baiu DC; Bhattacharya S; Titz B; Hebron E; Menapace BD; Singhal S; Eickhoff JC; Asimakopoulos F; Weichert JP; Otto M
Am J Cancer Res; 2015; 5(11):3422-35. PubMed ID: 26807322
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome of
Corroyer-Dulmont A; Falzone N; Kersemans V; Thompson J; Allen DP; Able S; Kartsonaki C; Malcolm J; Kinchesh P; Hill MA; Vojnovic B; Smart SC; Gaze MN; Vallis KA
Radiother Oncol; 2017 Sep; 124(3):488-495. PubMed ID: 28595752
[TBL] [Abstract][Full Text] [Related]
16. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
Rutgers M; Buitenhuis CK; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
[TBL] [Abstract][Full Text] [Related]
17. Rational evaluation of the therapeutic effect and dosimetry of auger electrons for radionuclide therapy in a cell culture model.
Shinohara A; Hanaoka H; Sakashita T; Sato T; Yamaguchi A; Ishioka NS; Tsushima Y
Ann Nucl Med; 2018 Feb; 32(2):114-122. PubMed ID: 29238922
[TBL] [Abstract][Full Text] [Related]
18. [(131)I] and [(125)I] metaiodobenzylguanidine therapy in macroscopic and microscopic tumors: a comparative study in SK-N-SH human neuroblastoma and PC12 rat pheochromocytoma xenografts.
Rutgers M; Buitenhuis CK; van der Valk MA; Hoefnagel CA; Voûte PA; Smets LA
Int J Cancer; 2000 Dec; 90(6):312-25. PubMed ID: 11180134
[TBL] [Abstract][Full Text] [Related]
19. Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents.
Bednarz B; Grudzinski J; Marsh I; Besemer A; Baiu D; Weichert J; Otto M
Health Phys; 2018 Apr; 114(4):450-459. PubMed ID: 29481536
[TBL] [Abstract][Full Text] [Related]
20. Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.
Weichert JP; Clark PA; Kandela IK; Vaccaro AM; Clarke W; Longino MA; Pinchuk AN; Farhoud M; Swanson KI; Floberg JM; Grudzinski J; Titz B; Traynor AM; Chen HE; Hall LT; Pazoles CJ; Pickhardt PJ; Kuo JS
Sci Transl Med; 2014 Jun; 6(240):240ra75. PubMed ID: 24920661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
